Evidence map›Paper›PMID 36366938›Full record

ReviewJournal of medical virology2023

Implementation of Public Health Genomics in Africa: Lessons from the COVID-19 pandemic, challenges, and recommendations.

Enos Moyo, Perseverance Moyo, Tapfumanei Mashe, Mathias Dzobo, Itai Chitungo, Tafadzwa Dzinamarira

Abstract readReview
In one paragraph

Review in Journal of medical virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Enos MoyoMedical Centre Oshakati, Oshakati, Namibia.ORCID 0000-0002-1827-9551
Perseverance MoyoMedical Centre Oshakati, Oshakati, Namibia.
Tapfumanei MasheWorld Health Organization, Harare, Zimbabwe.
Mathias DzoboSchool of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.ORCID 0000-0002-9910-0700
Itai ChitungoCollege of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Tafadzwa DzinamariraSchool of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Public Health Genomics (PHG) is a relatively new field. The wide application of genomic technologies played a pivotal role in elucidating the full genomic sequence of the SARS-CoV-2 virus. This breakthrough proved to be the starting point in the manufacture of diagnostic kits and the subsequent making of vaccines. Beyond the COVID-19 pandemic, many African countries can take advantage of the various investments in genomic technologies to introduce and intensify the use of genomics for public health gain. Public Health Genomics effectively monitors, prevents, and manages non-communicable and infectious diseases. However, there are several challenges to implementing PHG in Africa. In this perspective article, we discuss the utilization of PHG during the COVID-19 pandemic, the lessons learned from using PHG to manage and contain the COVID-19 pandemic, as well as potential challenges Africa may face when putting PHG into practice compared to challenges of other regions. We also discuss our recommendations for overcoming these challenges.

Indexed as

COVID-19AfricaHumansPandemicsPublic HealthSARS-CoV-2AfricabenefitschallengesCOVID-19Public Health Genomicsrecommendations

Identifiers

PMID36366938
PMCPMC9877907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.